Linear IgA/IgG bullous dermatosis successfully treated with omalizumab: A case report

Morten Bahrt Haulrig; Signe Ledou Nielsen; Jesper Elberling; Lone Skov

doi:10.1002/ccr3.5368

Linear IgA/IgG bullous dermatosis successfully treated with omalizumab: A case report

Morten Bahrt Haulrig, Signe Ledou Nielsen, Jesper Elberling, Lone Skov

Abstract

Linear IgA/IgG bullous dermatosis (LAGBD) is a rare, autoimmune blistering skin disease. We report a case of LAGBD in a 70-year-old woman. All common treatments were discontinued due to side effects or lack of treatment response. The patient was successfully treated with omalizumab which cleared her lesions after three months.

Original language	English
Journal	Clinical Case Reports
Volume	10
Issue number	3
Pages (from-to)	e05368
ISSN	2050-0904
DOIs	https://doi.org/10.1002/ccr3.5368
Publication status	Published - Mar 2022

Access to Document

10.1002/ccr3.5368

Cite this

@article{3ac4a19a13d0477f95c36ef791aacd7a,

title = "Linear IgA/IgG bullous dermatosis successfully treated with omalizumab: A case report",

abstract = "Linear IgA/IgG bullous dermatosis (LAGBD) is a rare, autoimmune blistering skin disease. We report a case of LAGBD in a 70-year-old woman. All common treatments were discontinued due to side effects or lack of treatment response. The patient was successfully treated with omalizumab which cleared her lesions after three months.",

author = "Haulrig, {Morten Bahrt} and Nielsen, {Signe Ledou} and Jesper Elberling and Lone Skov",

note = "{\textcopyright} 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.",

year = "2022",

month = mar,

doi = "10.1002/ccr3.5368",

language = "English",

volume = "10",

pages = "e05368",

journal = "Clinical Case Reports",

issn = "2050-0904",

publisher = "JohnWiley & Sons Ltd",

number = "3",

}

TY - JOUR

T1 - Linear IgA/IgG bullous dermatosis successfully treated with omalizumab

T2 - A case report

AU - Haulrig, Morten Bahrt

AU - Nielsen, Signe Ledou

AU - Elberling, Jesper

AU - Skov, Lone

PY - 2022/3

Y1 - 2022/3

N2 - Linear IgA/IgG bullous dermatosis (LAGBD) is a rare, autoimmune blistering skin disease. We report a case of LAGBD in a 70-year-old woman. All common treatments were discontinued due to side effects or lack of treatment response. The patient was successfully treated with omalizumab which cleared her lesions after three months.

AB - Linear IgA/IgG bullous dermatosis (LAGBD) is a rare, autoimmune blistering skin disease. We report a case of LAGBD in a 70-year-old woman. All common treatments were discontinued due to side effects or lack of treatment response. The patient was successfully treated with omalizumab which cleared her lesions after three months.

U2 - 10.1002/ccr3.5368

DO - 10.1002/ccr3.5368

M3 - Journal article

C2 - 35280104

VL - 10

SP - e05368

JO - Clinical Case Reports

JF - Clinical Case Reports

SN - 2050-0904

IS - 3

ER -

Linear IgA/IgG bullous dermatosis successfully treated with omalizumab: A case report

Abstract

Access to Document

Fingerprint

Cite this